HealthTech has the potential to address global health inequities by enhancing access to medical resources, facilitating telemedicine, and leveraging data analytics. Assessing its effectiveness requires a multi-faceted approach that embraces socio-economic factors.

Advancements in AI-driven drug development streamline research processes, enhance data analysis, and accelerate candidate identification. By leveraging machine learning algorithms, researchers can uncover novel drug interactions, optimize formulations, and significantly reduce time-to-market.